Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001950047-25-000883
Filing Date
2025-02-14
Accepted
2025-02-14 16:21:37
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 4016
  Complete submission text file 0001950047-25-000883.txt   5323
Mailing Address
Business Address
LYNCH DANIEL (Reporting) CIK: 0001177082 (see all company filings)

Type: 144

Mailing Address 100 WASHINGTON BOULEVARD STAMFORD CT 06902
Business Address 100 WASHINGTON BOULEVARD STAMFORD CT 06902 203-883-9490
SpringWorks Therapeutics, Inc. (Subject) CIK: 0001773427 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-39044 | Film No.: 25629292
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)